LEE; In-Hyun

Patent Applications and Registrations

Patent applications and USPTO patent grants for LEE; In-Hyun.The latest application filed is for "pharmaceutical composition for oral administration in powder formulation containing antiviral agent".

Company Profile

7.6.18

LEE; In-Hyun - Gwangju KR
Lee; In Hyun - Buk-gu Gwangju KR
Lee; In-Hyun - Yongin-si KR
Lee; In-Hyun - Seoul KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Composition For Oral Administration In Powder Formulation Containing Antiviral Agent App 20220296560 - JANG; Jun-Hee ; et al.	2022-09-22
Pharmaceutical composition for oral administration comprising taxane Grant 11,116,744 - Lee , et al. September 14, 2	2021-09-14
Pharmaceutical composition for oral administration comprising high concentration taxane Grant 11,020,370 - Lee , et al. June 1, 2	2021-06-01
Pharmaceutical composition for oral administration comprising high concentration taxane Grant 10,987,335 - Lee , et al. April 27, 2	2021-04-27
Pharmaceutical Composition For Oral Administration Comprising Taxane App 20200237707 - LEE; In-Hyun ; et al.	2020-07-30
Stable Pharmaceutical Composition Comprising Zanamivir App 20200230099 - Lee; In Hyun ; et al.	2020-07-23
Pharmaceutical composition for oral administration comprising taxane Grant 10,653,663 - Lee , et al.	2020-05-19
Pharmaceutical Composition For Oral Administration Comprising High Concentration Taxane App 20200085780 - LEE; In-Hyun ; et al.	2020-03-19
Pharmaceutical Composition For Oral Administration Comprising High Concentration Taxane App 20190000792 - LEE; In-Hyun ; et al.	2019-01-03
Pharmaceutical Composition For Oral Administration Comprising Taxane App 20170312244 - LEE; In-Hyun ; et al.	2017-11-02
Rechargeable lithium battery Grant 9,768,471 - Lee , et al. September 19, 2	2017-09-19
Transmucosal Delivery Of Pharmaceutical Active Substances App 20170252453 - JON; Sangyong ; et al.	2017-09-07
Rechargeable Lithium Battery App 20150288033 - Lee; In-Hyun ; et al.	2015-10-08
Transmucosal Delivery Of Pharmaceutical Active Substances App 20140256623 - JON; Sangyong ; et al.	2014-09-11
Rechargeable Battery App 20140141294 - Moon; Jong-Seok ; et al.	2014-05-22
Composition for solubilization of paclitaxel and preparation method thereof Grant 8,075,917 - Chung , et al. December 13, 2	2011-12-13
Oily Paclitaxel Composition And Formulation For Chemoembolization And Preparation Method Thereof App 20100041744 - Chung; Hesson ; et al.	2010-02-18
P-Glycoprotein inhibitor comprising octilonium bromide as an effective ingredient App 20100029755 - Chung; Hesson ; et al.	2010-02-04
Transmucosal Delivery Of Pharmaceutical Active Substances App 20070292387 - JON; Sangyong ; et al.	2007-12-20
P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredient App 20060141033 - Chung; Hesson ; et al.	2006-06-29
Mucoadhesive composition and formulation for solubilization of insoluble drugs and preparation method thereof App 20060134144 - Chung; Hesson ; et al.	2006-06-22
Paclitaxel composition for the intravesical treatment of bladder tumor and preparation method thereof App 20060127420 - Chung; Hesson ; et al.	2006-06-15
Composition for solubilization of paclitaxel and preparation method thereof App 20060104999 - Chung; Hesson ; et al.	2006-05-18
Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof App 20040241094 - Chung, Hesson ; et al.	2004-12-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.